Niagen Bioscience, Inc. (NAGE) Guidance & Earnings Results
On 2026-08-04 Niagen Bioscience, Inc. reaffirmed guidance: "E-commerce growth 10-15%…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NAGENiagen Bioscience, Inc.Follow NAGE — free
—
Price chart with a free account
- Market cap
- 192.3M
- P/E TTM
- 13.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 4 Aug 26 | Reaffirmed | E-commerce growth 10-15% YoY · full year |
| 6 May 26 | Raised | FY2026 net sales growth 10-15% YoY (ex-divested); G&A expense improved to $3-4M from $4-5M; S&M increasing as % of sales (previously stable) · full year |
| 4 Mar 26 | Raised | FY2026 net sales growth 10-15% |
| 4 Nov 25 | Raised | Full year 2025 net sales growth raised to 25-30% from 22-27% · full year |
| 6 Aug 25 | Raised | FY25 revenue growth raised to 22-27% from 20-25% · full year |
Niagen Bioscience, Inc. — questions
- What guidance did Niagen Bioscience, Inc. give?
- On 2026-08-04: "E-commerce growth 10-15% YoY"
- When does Niagen Bioscience, Inc. report earnings?
- Niagen Bioscience, Inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from Niagen Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.